2022 - Research.com Biology and Biochemistry in Italy Leader Award
2022 - Research.com Chemistry in Italy Leader Award
Claudiu T. Supuran mainly focuses on Carbonic anhydrase, Enzyme, Biochemistry, Stereochemistry and Isozyme. He interconnects Mechanism of action, Active site, Sulfonamide, Enzyme inhibitor and Acetazolamide in the investigation of issues within Carbonic anhydrase. His research investigates the connection with Enzyme and areas like Chemical synthesis which intersect with concerns in Medicinal chemistry.
His Biochemistry study combines topics from a wide range of disciplines, such as Bicarbonate and Pharmacology. His Stereochemistry study deals with Sulfamide intersecting with Sulfamic acid. The various areas that Claudiu T. Supuran examines in his Isozyme study include Enzyme activator, Phenols and Cytosol.
Claudiu T. Supuran spends much of his time researching Carbonic anhydrase, Biochemistry, Enzyme, Stereochemistry and Isozyme. His Carbonic anhydrase research incorporates elements of Active site, Cytosol, Sulfonamide, Enzyme inhibitor and Gene isoform. Claudiu T. Supuran has researched Biochemistry in several fields, including Sulfonamide and Acetazolamide.
His Acetazolamide research includes elements of Methazolamide and Ethoxzolamide. His Enzyme research focuses on subjects like Sulfamide, which are linked to Sulfamic acid. The Stereochemistry study combines topics in areas such as Selectivity, Structure–activity relationship, Carbonic anhydrase II and Carbonic Anhydrase I.
His primary areas of investigation include Carbonic anhydrase, Biochemistry, Gene isoform, Stereochemistry and Enzyme. His work focuses on many connections between Carbonic anhydrase and other disciplines, such as Cytosol, that overlap with his field of interest in Transmembrane protein. As a part of the same scientific study, Claudiu T. Supuran usually deals with the Biochemistry, concentrating on Bacteria and frequently concerns with Microbiology.
His research integrates issues of Inhibitory postsynaptic potential, Coumarin, Carbonic Anhydrase IX, Biological evaluation and Isozyme in his study of Gene isoform. The concepts of his Stereochemistry study are interwoven with issues in Aryl and Carbonic anhydrase II. The Enzyme study combines topics in areas such as Bicarbonate and Sulfamide.
Carbonic anhydrase, Biochemistry, Gene isoform, Stereochemistry and Enzyme are his primary areas of study. His Carbonic anhydrase research incorporates themes from In vitro, Active site, Molecular model, Coumarin and Sulfonamide. His Biochemistry research integrates issues from Cell culture and Inhibitory postsynaptic potential.
His Gene isoform study incorporates themes from Cancer cell, Carbonic anhydrase II, Selectivity, Structure–activity relationship and Acetazolamide. Claudiu T. Supuran has researched Stereochemistry in several fields, including Triazole and Biological activity. His work in Enzyme tackles topics such as Microbiology which are related to areas like Leishmania.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran.
Nature Reviews Drug Discovery (2008)
Interfering with pH regulation in tumours as a therapeutic strategy
Dario Neri;Claudiu T. Supuran.
Nature Reviews Drug Discovery (2011)
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
Vincenzo Alterio;Anna Di Fiore;Katia D’Ambrosio;Claudiu T. Supuran.
Chemical Reviews (2012)
Carbonic anhydrases: current state of the art, therapeutic applications and future prospects.
Silvia Pastorekova;Seppo Parkkila;Jaromir Pastorek;Claudiu T Supuran.
Journal of Enzyme Inhibition and Medicinal Chemistry (2004)
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.
Eliška Švastová;Alžbeta Hulı́ková;Monika Rafajová;Miriam Zat'ovičová.
FEBS Letters (2004)
Anticancer and antiviral sulfonamides.
Andrea Scozzafava;Takashi Owa;Antonio Mastrolorenzo;Claudiu T. Supuran.
Current Medicinal Chemistry (2003)
Carbonic anhydrase inhibitors
Claudiu T. Supuran.
Bioorganic & Medicinal Chemistry Letters (2003)
How many carbonic anhydrase inhibition mechanisms exist
Claudiu T. Supuran.
Journal of Enzyme Inhibition and Medicinal Chemistry (2016)
Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors
Yuanmei Lou;Paul C McDonald;Arusha Oloumi;Stephen K. Chia.
Cancer Research (2011)
Carbonic anhydrases as targets for medicinal chemistry
Claudiu T. Supuran;Andrea Scozzafava.
Bioorganic & Medicinal Chemistry (2007)
Journal of Enzyme Inhibition and Medicinal Chemistry
(Impact Factor: 5.756)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Florence
University of Florence
University of Florence
National Academies of Sciences, Engineering, and Medicine
University of Florence
University of Montpellier
National Academies of Sciences, Engineering, and Medicine
Tampere University
Atatürk University
King Saud University
University of Cambridge
Columbia University
Samsung (South Korea)
Memorial University of Newfoundland
Purdue University West Lafayette
National University of Singapore
University of Alicante
Villanova University
University of Tokyo
Tuscia University
University of New England
Claude Bernard University Lyon 1
University of Alberta
Johns Hopkins University School of Medicine
Cincinnati Children's Hospital Medical Center
University of Chicago